Catalyst Funds Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7M Buy
38,081
+36,077
+1,800% +$36.9M 2.56% 6
2026
Q1
$1.84M Buy
+2,004
New +$2.03M 0.31% 86
2024
Q4
Sell
-16,750
Closed -$14.8M 853
2024
Q3
$14.8M Buy
16,750
+14,300
+584% +$12.9M 3.26% 6
2024
Q2
$2.22M Buy
2,450
+1,600
+188% +$1.28M 0.59% 26
2024
Q1
$661K Buy
+850
New +$605K 0.18% 106

Other funds holding LLY

Catalyst Funds Management's LLY Position: Q2 2026 in Review

Catalyst Funds Management increased its Eli Lilly (LLY) stake by 1,800% in Q2 2026, buying an estimated $36.9M and bringing the position to 38,081 shares worth $45.7M. The position accounts for 2.56% of the portfolio, ranked #6.

Catalyst Funds Management first reported a position in LLY in Q1 2024 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Catalyst Funds Management held 38,081 shares of Eli Lilly worth $45.7M as of Q2 2026.
  • Catalyst Funds Management bought 36,077 Eli Lilly shares in Q2 2026, an estimated $36.9M.
  • Eli Lilly made up 2.56% of Catalyst Funds Management's portfolio in Q2 2026, its #6 holding.
  • Catalyst Funds Management first reported a position in Eli Lilly in Q1 2024 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.